Morasiewicz, P.; Zaborska, M.; Sobczak, M.; Tomczyk, Ł.; Leyko, P.; Bobiński, A.; Kochańska-Bieri, J.; Pili, D.; Kazubski, K.
The Use of Osteogenon as an Adjunctive Treatment in Lower Leg Fractures. Pharmaceuticals 2024, 17, 1531.
https://doi.org/10.3390/ph17111531
AMA Style
Morasiewicz P, Zaborska M, Sobczak M, Tomczyk Ł, Leyko P, Bobiński A, Kochańska-Bieri J, Pili D, Kazubski K.
The Use of Osteogenon as an Adjunctive Treatment in Lower Leg Fractures. Pharmaceuticals. 2024; 17(11):1531.
https://doi.org/10.3390/ph17111531
Chicago/Turabian Style
Morasiewicz, Piotr, Monika Zaborska, Michał Sobczak, Łukasz Tomczyk, Paweł Leyko, Andrzej Bobiński, Joanna Kochańska-Bieri, Daniele Pili, and Krystian Kazubski.
2024. "The Use of Osteogenon as an Adjunctive Treatment in Lower Leg Fractures" Pharmaceuticals 17, no. 11: 1531.
https://doi.org/10.3390/ph17111531
APA Style
Morasiewicz, P., Zaborska, M., Sobczak, M., Tomczyk, Ł., Leyko, P., Bobiński, A., Kochańska-Bieri, J., Pili, D., & Kazubski, K.
(2024). The Use of Osteogenon as an Adjunctive Treatment in Lower Leg Fractures. Pharmaceuticals, 17(11), 1531.
https://doi.org/10.3390/ph17111531
